Format

Send to

Choose Destination
Rheumatology (Oxford). 2014 Dec;53(12):2306-9. doi: 10.1093/rheumatology/ket445. Epub 2014 Apr 11.

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.

Author information

1
Department of Rheumatology, Norfolk and Norwich University Hospitals Foundation NHS Trust, Norwich, Medical School, University College London, London, City Hospital, Birmingham, Barking, Havering and Redbridge University NHS Trust, Romford, St Thomas' Hospital, London, University of Birmingham, Birmingham, Addenbrooke's Hospital, Cambridge, Nuffield Orthopaedic Centre, Oxford, Vasculitis UK, Matlock, School of Nursing and Midwifery, University of East Anglia, Norwich, Central Manchester Foundation Trust, Manchester, Ipswich Hospital NHS Trust, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK. Department of Rheumatology, Norfolk and Norwich University Hospitals Foundation NHS Trust, Norwich, Medical School, University College London, London, City Hospital, Birmingham, Barking, Havering and Redbridge University NHS Trust, Romford, St Thomas' Hospital, London, University of Birmingham, Birmingham, Addenbrooke's Hospital, Cambridge, Nuffield Orthopaedic Centre, Oxford, Vasculitis UK, Matlock, School of Nursing and Midwifery, University of East Anglia, Norwich, Central Manchester Foundation Trust, Manchester, Ipswich Hospital NHS Trust, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK. Richard.watts@ipswichhospital.nhs.uk.
2
Department of Rheumatology, Norfolk and Norwich University Hospitals Foundation NHS Trust, Norwich, Medical School, University College London, London, City Hospital, Birmingham, Barking, Havering and Redbridge University NHS Trust, Romford, St Thomas' Hospital, London, University of Birmingham, Birmingham, Addenbrooke's Hospital, Cambridge, Nuffield Orthopaedic Centre, Oxford, Vasculitis UK, Matlock, School of Nursing and Midwifery, University of East Anglia, Norwich, Central Manchester Foundation Trust, Manchester, Ipswich Hospital NHS Trust, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK.
3
Department of Rheumatology, Norfolk and Norwich University Hospitals Foundation NHS Trust, Norwich, Medical School, University College London, London, City Hospital, Birmingham, Barking, Havering and Redbridge University NHS Trust, Romford, St Thomas' Hospital, London, University of Birmingham, Birmingham, Addenbrooke's Hospital, Cambridge, Nuffield Orthopaedic Centre, Oxford, Vasculitis UK, Matlock, School of Nursing and Midwifery, University of East Anglia, Norwich, Central Manchester Foundation Trust, Manchester, Ipswich Hospital NHS Trust, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK. Department of Rheumatology, Norfolk and Norwich University Hospitals Foundation NHS Trust, Norwich, Medical School, University College London, London, City Hospital, Birmingham, Barking, Havering and Redbridge University NHS Trust, Romford, St Thomas' Hospital, London, University of Birmingham, Birmingham, Addenbrooke's Hospital, Cambridge, Nuffield Orthopaedic Centre, Oxford, Vasculitis UK, Matlock, School of Nursing and Midwifery, University of East Anglia, Norwich, Central Manchester Foundation Trust, Manchester, Ipswich Hospital NHS Trust, Ipswich and Norwich Medical School, University of East Anglia, Norwich, UK.

KEYWORDS:

cyclophosphamide; guideline; management; rituximab; vasculitis

Comment in

PMID:
24729399
DOI:
10.1093/rheumatology/ket445
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center